Americold Announces Second Quarter 2025 Results GlobeNewswire August 07, 2025 Launched Three Innovative and Demand-Driven Development Projects Delivered $0.36 AFFO per share Updated 2025 Full-Year Outlook ATLANTA, GA., Aug. 07, 2025 (GLOBE NEWSWIRE) — Americold Realty Trust, Inc. (NYSE: COLD) (the “Company”), a global leader in temperature-controlled logistics, real estate, and value-added services focused on […]

GoHealth Announces Strategic Capital and Governance Actions to Support Long-Term Value Creation and Reports Second Quarter 2025 Results GlobeNewswire August 07, 2025 CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced the execution of strategic capital and

Supremex Announces Results for the Second Quarter of 2025, a Special Dividend of $0.50 Per Common Share, the Renewal of Its Normal Course Issuer Bid and Completes Two Tuck-In Acquisitions Subsequent to the End of the Quarter GlobeNewswire August 07, 2025 MONTREAL, Aug. 07, 2025 (GLOBE NEWSWIRE) — Supremex Inc. (“Supremex” or the “Company”) (TSX:

C4 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights GlobeNewswire August 07, 2025 Cemsidomide Phase 1 Data in Multiple Myeloma Accepted as an Oral Presentation at the International Myeloma Society (IMS) Annual Meeting; As of the July 23, 2025, Data Cutoff, Phase 1 ORR Remains at 40% at the 75 ug Dose

Stella-Jones Announces Second Quarter Results Executing on infrastructure-focused growth strategy GlobeNewswire August 07, 2025 Sales of $1,034 million, down 1% from Q2 2024 Operating income of $155 million vs $168 million in Q2 2024 Strong EBITDA(1) of $189 million, or 18.3% margin(1) Completed acquisition of a steel transmission structure manufacturer Available liquidity of almost $700

Chicago Atlantic Real Estate Finance Announces Second Quarter 2025 Financial Results Extends Revolving Credit Facility Maturity to 2028 GlobeNewswire August 07, 2025 CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) (“Chicago Atlantic” or the “Company”), a commercial mortgage real estate investment trust, today announced its results for the

Cartesian Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 07, 2025 Initiated Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Preliminary data from Phase 2 trial of Descartes-08 in systemic lupus erythematosus expected in 2H25 Initiation of Phase 2 pediatric basket trial of Descartes-08 in select autoimmune indications expected

Visible Copper Mineralization in Drill Core and Rock Samples Up to 26% Copper and 5.73 Grams Per Tonne Gold at Yukon Metals' AZ Property GlobeNewswire August 07, 2025 VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) (“Yukon Metals” or the “Company“) is pleased to provide

Lee Enterprises reports third quarter Adjusted EBITDA growth GlobeNewswire August 07, 2025 Adjusted EBITDA(1) growth of 92% over Q2Total Digital Revenue(2) of $78M represented 55% of total revenueDigital-Only subscription revenue increased 16% YOY(3)Amplified Digital(R) Agency revenue totaled $29M, or up 10% YOY(3) DAVENPORT, Iowa, Aug. 07, 2025 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NASDAQ: LEE),

Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update GlobeNewswire August 07, 2025 RAP-219 Phase 2a trial in patients with drug-resistant focal onset seizures is fully enrolled and on track for topline results in September 2025 Phase 2 trial of RAP-219 in bipolar mania has been initiated and is enrolling patients; trial remains